Navigation Links
ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical,Model

are for a phase 2 clinical trial in multiple myeloma later this year".

Acceleron is developing therapeutics that addresses the clinical consequences of cancer, such as bone loss and/or muscle loss, as well as treatments that directly target the underlying tumor. Given the improving therapeutic outcomes leading to more cancer patients living longer with their disease, the frequency of secondary consequences of cancer is increasing.

About ACE-011

ACE-011, a novel bone anabolic agent currently in a phase 1 clinical trial, is a protein therapeutic based on the activin receptor IIA. In numerous preclinical models of bone loss, ACE-011 has demonstrated beneficial effects on both trabecular and cortical bone. ACE-011 increased bone mineral density, improved bone architecture, increased the mineral apposition and bone formation rates and improved bone mechanical strength. These effects have been demonstrated in therapeutic models of bone loss in which ACE-011 has stimulated bone formation - a significant unmet medical need that is underserved by current treatments for bone loss.

About Multiple Myeloma

Multiple myeloma is a malignancy of plasma cells in the bone marrow that disrupts normal bone marrow function. Myeloma cells invade and destroy the bone surrounding the marrow cavity leading to rapid and widespread osteoporosis and osteolytic bone lesions, resulting in fractures, vertebral compressions and bone pain. Intravenous bisphosphonates are the current standard of care, but significant unmet medical need remains since most patients will still have serious bone complications despite treatment. According to the International Myeloma Foundation, there are an estimated 750,000 people worldwide multiple myeloma. In the US and EU, there are approximately 80,000 myeloma patients whose disease has affected their bones.

About Acceleron Pharma

Acceleron is a privately held biopharmaceutical company committed to discover, develop,
'"/>




Page: 1 2 3

Related medicine technology :

1. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
2. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
3. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
4. Data Presented at SLEEP 2007 Shows VEC-162 Improves Sleep Onset and Maintenance vs. Placebo
5. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
6. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
7. Adding Thalidomide to Standard Therapy Improves Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
8. First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A) Significantly Improves Idiopathic Detrusor Overactivity (IDO) in Patients With Symptoms of Overactive Bladder
9. Newly Published Study Reveals Femara Improves Chances for Harder to Treat Early Breast Cancer Relapse in Postmenopausal Women
10. Once Daily, Extended-Release Ropinirole Improves Parkinsons Symptoms in Patients not Optimally Controlled With Levodopa
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ACE Improves Multiple Myeloma Bone Disease Preclinical Model
(Date:7/23/2014)... , July 23, 2014 On Tuesday, ... ("Plaintiff") filed suit in the 116 th ... , against RegenLab USA, LLC ... Prospective Business Relationships through false and misleading ... Business Disparagement through libel, disparagement, defamation, ...
(Date:7/23/2014)... July 23, 2014 /PRNewswire-iReach/ -- The Centers for Medicare ... Quality Innovation Network-Quality Improvement Organization (QIN-QIO) contract to a ... Effective August 1, WVMI will launch Quality ... , Pennsylvania , ... and Louisiana.  The Network will engage providers and the ...
(Date:7/23/2014)... -- RT Oncology Services Corporation today announced that Craig ... directors. Mr. Mundie is currently senior advisor to the ... projects within the company and on technology strategy and ... officer. Mike Martin , president ... a visionary technology executive. His appointment is part of ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3
... , , WALTHAM, Mass., ... research and advisory firms for pharmaceutical and healthcare issues, finds ... cause the schizophrenia drug market to decrease from $6.3 billion ... States, France, Germany, Italy, Spain, the United Kingdom and Japan. ...
... , , BIRMINGHAM, Ala., Dec. 2 ... cancer. For adults 65 and over, the odds of losing vision are ... are one in six and odds of a woman developing breast cancer ... aging adults by increasing the risk of injuries, depression and inability to ...
Cached Medicine Technology:Generic Erosion of Established Branded Atypical Antipsychotics Will Cause the Schizophrenia Drug Market To Decline More Than $1 Billion by 2013 2Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2
(Date:7/23/2014)... 23, 2014 Recently, Agebc.com has launched ... the company is announcing a promotion of wedding dresses. ... will end at the end of this month. , ... popular styles, like A-line, mermaid, ball-gown, empire, and more. ... and other special-occasion dresses for women, and the company ...
(Date:7/23/2014)... July 23, 2014 Absolute PhysioCare and ... the launch of its custom orthotics and gait scan ... foot abnormalities in order to restore normal body balance. ... cause less fatigue and pain. In addition, Custom orthotics ... in the foot, resulting in relief and greater comfort ...
(Date:7/23/2014)... In his latest blog post at http://www.perwickstrom.com ... Per Wickstrom explains why entrepreneurs should plan for failure. ... he has never failed – and quite miserably at ... “Failure is not the opposite of success; it is ... reveals opportunities and shifts perspectives that, ultimately, are essential ...
(Date:7/23/2014)... 23, 2014 A Forever Recovery, an ... off to a great start and gives them a ... launched a new Internet Addiction section of its website ... to learn that Internet addiction is not just as ... but that it’s trapping more and more victims each ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 In its latest ... programs and believes that having family close by during a ... or not the process is successful, is focusing on a ... all drug and addiction-related dialogues: opiate abuse facts. , The ... , An overview of opiates, and why ...
Breaking Medicine News(10 mins):Health News:Agebc.com Launched Its New Collection of Wedding Dresses 2Health News:Custom Orthotics at Burnaby PhysioCare Now Correct Foot Abnormalities 2Health News:Per Wickstrom’s Latest Blog Post Explains why Entrepreneurs Should Plan for Failure 2Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:Latest Best Drug Rehabilitation Blog Post Focuses on Opiate Abuse Facts 2
... expected to be launched in New Zealand soon, targeting ... Soon, men might also be given cervical cancer vaccines ... to protect themselves against several diseases. ... of cervical cancer prevention. Most cases of cervical cancer ...
... European Union has a huge health problem of having ... ailment in the Union, that costed the bloc’s members, a ... // ,Take a look at the annual ... disease ruled, making a dent of 230 euros on an ...
... that plays a crucial role in deciding if an embryo ... gene develops into a male), could explain the high incidence ... for formation of testes is also produced by Parkinson's affected ... and University of California. ,The SRY gene was ...
... A new research at the National Institutes of Health ... by modifying the lifestyle choices, such as exercise, learning ... published in the journal Alzheimer's & Dementia. ... Affairs for the Alzheimer's Association said that specific combinations ...
... said that the number of children born out of wedlock has ... The ONS Social// Trends survey also found that in 13 other ... ,The survey said that the size of the average UK household ... "Although most children are born to married couples, this substantial rise ...
... than famous, is now going to face some competition. Private ... Canada, having garnered enough support from the several provinces in ... the Quebec government, which intended to remove the ban on ... offered to chip in and pick up costs for such ...
Cached Medicine News:Health News:Men Might Get Their Share of Cervical Cancer Vaccine As Well 2Health News:Sex Determination Gene Blamed For High Incidence Of Parkinson’s In Me 2Health News:Cognitive deterioration in the older generation can be prevented by modifying the lifestyle 2
For the direct quantitative determination of low density lipoprotein cholesterol (LDL-C) in human serum or plasma. For in vitro diagnostic use only....
Storage temperature: 15 - 30C, linearity: 0 - 20 mg/dL, expected value: male: 3.0 - 7.0 mg/dL and female: 2.2 - 6.2 mg/dL. Available with calibrator and number of tests 125....
Intended for the quantitative determination of uric acid in serum or plasma. Reaction: endpoint. Wavelength: 520 nm. Linearity: 20 mg/dL (1190 mol/L). Single vial, dry powder reagent....
... A fully automated, random ... over 50 assays available ... tumor marker, therapeutic drug, ... testing can be performed ...
Medicine Products: